Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplant-eligible Patients”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02237261
What this trial is testing

Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital Heidelberg 46
Testing effectiveness (Phase 2)UnknownNCT05243693
What this trial is testing

Brentuximab Vedotin Plus DHAP in Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Relapsed/Refractory Classical Hodgkin Lymphoma
National Cancer Center, Korea 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04476199
What this trial is testing

Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Trapianto di Midollo Osseo 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07624513
What this trial is testing

D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMM

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 720
Testing effectiveness (Phase 2)Looking for participantsNCT07451652
What this trial is testing

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

Who this might be right for
Relapsed/Refractory Diffuse Large B Cell Lymphoma
Hospital Universitario Dr. Jose E. Gonzalez 10
Not applicableActive Not RecruitingNCT06799728
What this trial is testing

Uterus Transplantation: Acceptability of the Procedure in Eligible Patients

Who this might be right for
Focus: Uterus Transplant ProcedureAcceptability of the Uterus Transplantation Procedure
IRCCS Azienda Ospedaliero-Universitaria di Bologna 150
Testing effectiveness (Phase 2)Study completedNCT02203643
What this trial is testing

Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.

Who this might be right for
MULTIPLE MYELOMA (MM)
Mario Boccadoro 477
Testing effectiveness (Phase 2)WithdrawnNCT06180863
What this trial is testing

Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia
Yale University
Testing effectiveness (Phase 2)WithdrawnNCT04258683
What this trial is testing

Pembrolizumab Added to the Standard First-Line Therapy of Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) for NDMM NTE

Who this might be right for
Multiple Myeloma
Canadian Myeloma Research Group
Testing effectiveness (Phase 2)Study completedNCT00682305
What this trial is testing

Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Universitätsklinikum Hamburg-Eppendorf 50
Not applicableStudy completedNCT01941680
What this trial is testing

High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant

Who this might be right for
T-cell LymphomaLeukaemia
University Hospital Center of Martinique 20
Not applicableLooking for participantsNCT06299553
What this trial is testing

Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Incyte Biosciences Italy S.r.l 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04626791
What this trial is testing

Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Academic and Community Cancer Research United 41
Not applicableLooking for participantsNCT07420790
What this trial is testing

Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial

Who this might be right for
Acute Myeloid Leukemia
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 1,941
Early research (Phase 1)Study completedNCT01440582
What this trial is testing

Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 77
Large-scale testing (Phase 3)Study completedNCT02197221
What this trial is testing

Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 300
Large-scale testing (Phase 3)Not Yet RecruitingNCT07671287
What this trial is testing

GMMG-HD11/DSMM XXI/64007957MMY3010

Who this might be right for
Multiple Myeloma
University of Heidelberg Medical Center 399
Large-scale testing (Phase 3)UnknownNCT04758806
What this trial is testing

Fecal Microbial Transplantation in Severe Alcoholic Hepatitis

Who this might be right for
Alcoholic Hepatitis
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica 50
Testing effectiveness (Phase 2)Study completedNCT03477539
What this trial is testing

Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma

Who this might be right for
Plasma Cell Myeloma
Mayo Clinic 49
Large-scale testing (Phase 3)Study completedNCT03402295
What this trial is testing

Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation

Who this might be right for
Multiple MyelomaEffects of Chemotherapy
Grupo de Estudos Multicentricos em Onco-Hematologia 311
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation